Youxin Seeks 4,000x Authorised Share Increase and Two Consolidations at Nov 6 AGM

summarizeSummary

Youxin's AGM proxy asks shareholders to approve a roughly 4,000x increase in authorised Class A shares, a 6-for-1 consolidation, a par-value reduction to USD0.00001, and a second 10:1 to 100:1 consolidation. No shares are being sold — this is authorisation only, but it creates vast room for future dilution.

check_boxKey Events · Financing and Capital Events · YAAS

• Authorised Capital Raised ~4,000x

  Authorised Class A shares would go from 40,950,000 to 163,800,000,000 (par USD0.04), lifting total authorised capital from USD1,640,000 to USD6,552,002,000. No shares are being issued under this resolution.

• Two Consolidations Proposed

  A 6-for-1 Class A consolidation to USD0.24 par would follow the increase, then a second consolidation of 10:1 to 100:1 with the ratio set by the board and conditional on Nasdaq notification by the first anniversary of the meeting.

• Par Value Cut to USD0.00001

  The capital reduction cancels USD0.23999 of paid-up capital per Class A share and USD0.00009 per Class B share, moving the credit to a distributable reserve that can be used to offset accumulated losses.

• AGM Set for November 6, 2026

  Record date is October 16, 2026, with 15,714,659 ordinary shares outstanding. Directors and officers hold 56.92% of the vote and are expected to vote in favour, making passage effectively certain.

auto_awesomeAnalysis · YAAS · Technology

Youxin is asking shareholders to approve a chain of capital-structure changes that, taken together, give the board room to issue an enormous number of new shares and then repeatedly consolidate them. Authorised Class A shares would rise from 40.95 million to 163.8 billion — roughly 4,000 times the current authorisation — before a 6-for-1 consolidation and a par-value cut to USD0.00001. A second consolidation of 10:1 to 100:1 would follow, with the exact ratio left to the board and conditional on Nasdaq notification. The par-value reduction also creates a distributable reserve the company can use to write off accumulated losses, which matters given the first-half loss reported in August. No shares have been issued and no proceeds are being raised here; this is permission, not dilution. But the scale of the headroom, combined with the existing $100M shelf and $6.35M ATM, means the board is building capacity for substantial future issuance — and the repeated consolidations suggest the share price is under pressure. Directors and officers hold 56.92% of the vote, so approval is effectively assured.